tiprankstipranks
ImmunityBio receives FDA RMAT designation for Anktiva
PremiumThe FlyImmunityBio receives FDA RMAT designation for Anktiva
25d ago
ImmunityBio receives FDA RMAT designation for Anktiva
Premium
The Fly
ImmunityBio receives FDA RMAT designation for Anktiva
25d ago
Buy Rating for ImmunityBio Driven by FDA Authorization and Market Growth Prospects
Premium
Ratings
Buy Rating for ImmunityBio Driven by FDA Authorization and Market Growth Prospects
1M ago
Starbucks reports Q1 beat, Frontier proposes Spirit combination: Morning Buzz
PremiumThe FlyStarbucks reports Q1 beat, Frontier proposes Spirit combination: Morning Buzz
2M ago
ImmunityBio enters collaboration with BeiGene on Anktiva trial
Premium
The Fly
ImmunityBio enters collaboration with BeiGene on Anktiva trial
2M ago
ImmunityBio announces Anktiva MAA accepted for review by EMA
Premium
The Fly
ImmunityBio announces Anktiva MAA accepted for review by EMA
2M ago
Albertsons terminates Kroger deal, Macy’s reports Q3 beat: Morning Buzz
PremiumThe FlyAlbertsons terminates Kroger deal, Macy’s reports Q3 beat: Morning Buzz
3M ago
ImmunityBio 33.333M share Spot Secondary priced at $3.00
Premium
The Fly
ImmunityBio 33.333M share Spot Secondary priced at $3.00
3M ago
ImmunityBio announces common stock offering, no amount given
Premium
The Fly
ImmunityBio announces common stock offering, no amount given
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100